↓ Skip to main content

Sumatriptan plus naproxen for acute migraine attacks in adults

Overview of attention for article published in this source, October 2013
Altmetric Badge

Mentioned by

1 blog
1 policy source
24 X users
1 Wikipedia page


23 Dimensions

Readers on

76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Sumatriptan plus naproxen for acute migraine attacks in adults
Published by
John Wiley & Sons, Ltd, October 2013
DOI 10.1002/14651858.cd008541.pub2
Pubmed ID

Law, Simon, Derry, Sheena, Moore, R Andrew


Migraine is a common disabling condition and a burden for the individual, health services, and society. Effective abortive treatments include the triptan and non-steroidal anti-inflammatory classes of drugs. These drugs have different mechanisms of action and combining them may provide better relief. Sumatriptan plus naproxen is now available in combination form for the acute treatment of migraine.

X Demographics

X Demographics

The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 1%
Brazil 1 1%
United Kingdom 1 1%
Spain 1 1%
United States 1 1%
Unknown 71 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 16%
Researcher 11 14%
Student > Bachelor 10 13%
Student > Master 9 12%
Other 6 8%
Other 13 17%
Unknown 15 20%
Readers by discipline Count As %
Medicine and Dentistry 33 43%
Psychology 5 7%
Nursing and Health Professions 4 5%
Neuroscience 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 10 13%
Unknown 17 22%